ArticleScientific reports2026
Deep learning framework with interpretable feature selection for accurate SUMOylation site prediction.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- DeepFusion-ACSM: an interpretable hybrid ML-DL ensemble model for anticancer small-molecule activity prediction.Journal of computer-aided molecular design · 2026Article
- Deep learning-based identification of N6-methyladenine sites via hybrid feature fusion and SHAP-driven feature selection.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small ubiquitin-like modifiers (SUMOs) are crucial protein regulators influencing diverse biological processes through covalent modifications or non-covalent interactions. SUMOylation, a key post-translational modification (PTM), plays a vital role in cellular regulation. This study presents Hybrid-Sumo, a deep learning-based model integrating protein structural and sequence features to predict SUMOylation sites. Hybrid-Sumo combines three advanced feature extraction techniques: Half-Sphere Exposure (HSE), Position-Specific Scoring Matrix with Discrete Wavelet Transform (PSSM-DWT), and Bidirectional Encoder Representations from Transformers (BERT). The SHapley Additive exPlanations (SHAP) algorithm is employed for optimal feature selection, while a Deep Neural Network (DNN) serves as the classification model. Extensive 10-fold cross-validation confirms the effectiveness of Hybrid-Sumo, achieving 99.74% accuracy on benchmark datasets and 96.15% and 95.83% on balanced and imbalanced independent datasets, respectively. These results surpass existing models, improving training accuracy by 1.45% and testing accuracy (both balanced and imbalanced) by 1.90% and 0.25%, respectively. These findings highlight Hybrid-Sumo as a robust computational tool for accurate prediction of SUMOylation sites, accelerating research on protein function and modification analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.